These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 23484886)

  • 21. Medical emergency preparedness in office practice.
    Toback SL
    Am Fam Physician; 2007 Jun; 75(11):1679-84. PubMed ID: 17575658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for fatal and nonfatal reactions to immunotherapy (2008-2018): postinjection monitoring and severe asthma.
    Epstein TG; Murphy-Berendts K; Liss GM; Bernstein DI
    Ann Allergy Asthma Immunol; 2021 Jul; 127(1):64-69.e1. PubMed ID: 33753219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention and management of office allergy emergencies.
    Gordon BR
    Otolaryngol Clin North Am; 1992 Feb; 25(1):119-34. PubMed ID: 1549377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anaphylaxis on the other front line: perspectives from the emergency department.
    Nowak RM; Macias CG
    Am J Med; 2014 Jan; 127(1 Suppl):S34-44. PubMed ID: 24384136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A practical guide to anaphylaxis.
    Tang AW
    Am Fam Physician; 2003 Oct; 68(7):1325-32. PubMed ID: 14567487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic reactions to subcutaneous allergen immunotherapy.
    Bernstein DI; Epstein T
    Immunol Allergy Clin North Am; 2011 May; 31(2):241-9, viii-ix. PubMed ID: 21530817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An update on allergic emergencies.
    Toy D; Braga MS; Greenhawt M; Shaker M
    Curr Opin Pediatr; 2019 Jun; 31(3):426-432. PubMed ID: 31090587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of epinephrine and diphenhydramine rinses in decreasing local reactions to subcutaneous aeroallergen immunotherapy.
    Mustafa SS; Vadamalai K; Bingemann T; Ramsey A
    Allergy Asthma Proc; 2020 Jan; 41(1):52-58. PubMed ID: 31888783
    [No Abstract]   [Full Text] [Related]  

  • 29. Recognition and treatment of anaphylaxis in the school setting: the essential role of the school nurse.
    Schoessler S; White MV
    J Sch Nurs; 2013 Dec; 29(6):407-15. PubMed ID: 24062364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunotherapy safety: what have we learned from surveillance surveys?
    Kannan JA; Epstein TG
    Curr Allergy Asthma Rep; 2013 Aug; 13(4):381-8. PubMed ID: 23636820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. American Academy of Allergy, Asthma & Immunology membership experience with allergen immunotherapy safety in patients with specific medical conditions.
    Larenas-Linnemann DE; Hauswirth DW; Calabria CW; Sher LD; Rank MA
    Allergy Asthma Proc; 2016 Sep; 37(5):112-22. PubMed ID: 27657518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of Anaphylaxis.
    Lee SE
    Otolaryngol Clin North Am; 2017 Dec; 50(6):1175-1184. PubMed ID: 29103454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atrial fibrillation associated with anaphylaxis during venom and pollen immunotherapy.
    Patel SC; Detjen PF
    Ann Allergy Asthma Immunol; 2002 Aug; 89(2):209-11. PubMed ID: 12197580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Canadian allergists' and nonallergists' perception of epinephrine use and vaccination of persons with egg allergy.
    Desjardins M; Clarke A; Alizadehfar R; Grenier D; Eisman H; Carr S; Vander Leek TK; Teperman L; Higgins N; Joseph L; Shand G; Ben-Shoshan M
    J Allergy Clin Immunol Pract; 2013; 1(3):289-94. PubMed ID: 24565487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 911 in your office: preparations to keep emergencies from becoming catastrophes.
    Schexnayder SM; Schexnayder RE
    Pediatr Ann; 1996 Dec; 25(12):664-6, 668, 670, passim. PubMed ID: 8971873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention and treatment of anaphylaxis.
    Kemp SF; deShazo RD
    Clin Allergy Immunol; 2008; 21():477-98. PubMed ID: 18828525
    [No Abstract]   [Full Text] [Related]  

  • 37. Surveillance of systemic reactions to subcutaneous immunotherapy injections: year 1 outcomes of the ACAAI and AAAAI collaborative study.
    Bernstein DI; Epstein T; Murphy-Berendts K; Liss GM
    Ann Allergy Asthma Immunol; 2010 Jun; 104(6):530-5. PubMed ID: 20568387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence and risk factors for subcutaneous immunotherapy anaphylaxis: the optimization of safety.
    Caminati M; Dama AR; Djuric I; Montagni M; Schiappoli M; Ridolo E; Senna G; Canonica GW
    Expert Rev Clin Immunol; 2015 Feb; 11(2):233-45. PubMed ID: 25484197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation for emergencies in the offices of pediatricians and pediatric primary care providers.
    ; Frush K
    Pediatrics; 2007 Jul; 120(1):200-12. PubMed ID: 17606580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anaphylaxis and epinephrine prescribing patterns in a military hospital: underutilization of the intramuscular route.
    Haymore BR; Carr WW; Frank WT
    Allergy Asthma Proc; 2005; 26(5):361-5. PubMed ID: 16450570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.